A comparison of economic aspects of hospitalization versus ambulatory care in the management of neuritis occurring in lepra reaction.
Neuritis is one of the important causes of deformities and disabilities in leprosy. Neuritis has been managed both in the field and in hospital. This study was done to compare the economic aspects of cost of ambulatory vs in-patient management of neuritis in leprosy. The quality of life of the affected patients and the clinical improvement in the 2 groups were also studied. Twenty six patients fulfilling the study criteria were randomized into the ambulatory and in-patient group (13 in each group). The primary outcome examined was cost, in various categories; the secondary outcomes included pre- and post-treatment comparison of Quality of Life (QOL) scores and tests of sensory and motor function. The direct and indirect medical costs incurred by patients in the hospitalized group were higher than those patients in the ambulatory group. The difference in the direct medical costs between the two groups was Rs. 9110.5, and the extra direct non medical costs incurred by patients in the hospitalized group was Rs. 888.50 because of more frequent visits of family members. A greater percentage of ambulatory than in-patients returned to work in </= 15 days (53.8% vs 15.3%), and the mean duration before returning to work was 19.5 days ambulatory patients compared to 66.8 days for in-patients group. The QOL scores and motor and sensory function tests showed no significant difference between groups. Although the sample size was small, these preliminary results suggest that substantial cost minimization by ambulatory care is possible without significantly affecting the quality of life or peripheral nerve function.
H N
Ravi
R
Department of Dermatology, Venereology and Leprology, Christian Medical College, Vellore 632 002, Tamilnadu, India.
George
Renu
R
Eapen
Elizabeth P
EP
Pulimood
Susanne A
SA
Gnanamuthu
Chandran
C
Jacob
Mary
M
John
K R
KR
D000293:Adolescent; D000328:Adult; D000553:Ambulatory Care / Q000191:economics*; D017281:Cost of Illness; D003365:Costs and Cost Analysis; D005260:Female; D017048:Health Care Costs; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D007918:Leprosy / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009443:Neuritis / Q000191:economics* / Q000628:therapy*; D011788:Quality of Life; D016896:Treatment Outcome